We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+37.44%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.04B
AUM Growth
+$198M
Cap. Flow
+$14M
Cap. Flow %
1.35%
Top 10 Hldgs %
42.78%
Holding
150
New
56
Increased
28
Reduced
29
Closed
29

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$12.9M
2
LHCG
LHC Group LLC
LHCG
+$9.74M
3
CNMD icon
CONMED
CNMD
+$7.65M
4
LIVN icon
LivaNova
LIVN
+$7.59M
5
IMVT icon
Immunovant
IMVT
+$5.8M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.47M
2
XLRN
Acceleron Pharma
XLRN
+$5.43M
3
STAA icon
STAAR Surgical
STAA
+$5.36M
4
QDEL icon
QuidelOrtho
QDEL
+$5.09M
5
ADPT icon
Adaptive Biotechnologies
ADPT
+$4.68M

Sector Composition

Rank Sector Weight
1 Healthcare 38.45%
2 Industrials 1.39%
3 Energy 1.11%
4 Consumer Discretionary 0.31%
5 Consumer Staples 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWM icon
1
PUT
iShares Russell 2000 ETF
IWM
$82.1B
$88.3M 8.5%
617,000
+338,200
+121% +$44.4M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$818B
$87.6M 8.42%
284,000
-58,700
-17% -$17.2M
IHI icon
3
PUT
iShares US Medical Devices ETF
IHI
$3.36B
$49.8M 4.79%
+1,128,000
New +$48.2M
XLV icon
4
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.4B
$38.3M 3.69%
383,000
-370,000
-49% -$36.5M
XBI icon
5
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$37.2M 3.57%
332,000
-288,000
-46% -$28.4M
NSTG
6
DELISTED
NanoString Technologies, Inc.
NSTG
$31.1M 2.99%
1,060,731
+149,478
+16% +$4.45M
ATRC icon
7
AtriCure
ATRC
$2.01B
$30.8M 2.96%
685,273
+296,279
+76% +$12.9M
INSP icon
8
Inspire Medical Systems
INSP
$1.7B
$29.3M 2.82%
337,016
-27,964
-8% -$2.15M
SYK icon
9
PUT
Stryker
SYK
$129B
$27.6M 2.65%
+153,000
New +$28.2M
ICUI icon
10
ICU Medical
ICUI
$4.16B
$24.7M 2.38%
134,251
+7,467
+6% +$1.48M
ALXN
11
DELISTED
Alexion Pharmaceuticals
ALXN
$23M 2.21%
204,696
-3,300
-2% -$350K
ALXN
12
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
$22.9M 2.2%
204,000
+4,000
+2% +$425K
STAA icon
13
STAAR Surgical
STAA
$1.15B
$22M 2.12%
357,780
-131,170
-27% -$5.36M
SRPT icon
14
PUT
Sarepta Therapeutics
SRPT
$1.77B
$21.2M 2.04%
132,400
+3,000
+2% +$408K
INOV
15
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$20.2M 1.94%
1,047,216
-56,824
-5% -$1.01M
BMY icon
16
CALL
Bristol-Myers Squibb
BMY
$131B
$18M 1.73%
+306,000
New +$18.3M
ESTA icon
17
Establishment Labs
ESTA
$2.33B
$17.7M 1.7%
944,958
+66,731
+8% +$1.13M
UNH icon
18
PUT
UnitedHealth
UNH
$367B
$16.8M 1.62%
+57,000
New +$16.3M
VRAY
19
DELISTED
ViewRay, Inc.
VRAY
$15.3M 1.47%
6,842,954
-61,674
-0.9% -$132K
VEEV icon
20
PUT
Veeva Systems
VEEV
$35.4B
$14.3M 1.38%
+61,000
New +$12.1M
XENT
21
DELISTED
Intersect ENT, Inc
XENT
$13.9M 1.33%
1,024,374
+342,509
+50% +$3.98M
LHCG
22
DELISTED
LHC Group LLC
LHCG
$11.6M 1.11%
+66,359
New +$9.74M
IMDX
23
Insight Molecular Diagnostics
IMDX
$155M
$11.4M 1.1%
299,186
+20,272
+7% +$1.05M
IVC
24
DELISTED
Invacare Corporation
IVC
$10.2M 0.98%
1,595,609
-12,237
-0.8% -$81.9K
DXCM icon
25
DexCom
DXCM
$31.3B
$9.93M 0.95%
97,932
-50,800
-34% -$4.54M
1
2 3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
ONGA
O'Neil Global Advisors Los Angeles, California $14.4M AUM 220.73% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM

Pura Vida Investments's Q2 2020 Portfolio in Review

As of Q2 2020, Pura Vida Investments held 150 positions worth $1.04B, up 23% from $842M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Pura Vida Investments's Q2 2020 filing shows 56 new, 28 increased, 29 reduced and 29 closed positions. Its largest new stake was LHC Group LLC: 66,359 shares worth $11.6M. The largest sale was Regeneron Pharmaceuticals, an estimated $5.47M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Industrials and Energy.

  • Pura Vida Investments's largest Q2 2020 buy was LHC Group LLC: 66,359 shares worth $11.6M.
  • Pura Vida Investments added most to AtriCure in Q2 2020, an estimated $12.9M increase.
  • Pura Vida Investments's biggest Q2 2020 reduction was Acceleron Pharma, cutting an estimated $5.43M.
  • Pura Vida Investments fully exited Regeneron Pharmaceuticals in Q2 2020, selling an estimated $5.47M.
  • Pura Vida Investments's ten largest holdings make up 43% of its $1.04B portfolio in Q2 2020.
  • Pura Vida Investments opened 56 new positions and closed 29 in Q2 2020.
  • Pura Vida Investments's portfolio value rose 23% quarter-over-quarter to $1.04B.

Based on Pura Vida Investments's 13F filing for Q2 2020, filed 14 Aug 2020.